Cargando…

DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity

BACKGROUND: Human papillomavirus (HPV) pseudovirions have recently been shown to deliver DNA efficiently in vivo, resulting in the priming of antigen-specific CD8+ T cells in vaccinated mice. In the current study, we compare the different preparation methods for the generation of HPV pseudovirions f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Shiwen, Ma, Barbara, Chen, Shu-Hsia, Hung, Chien-Fu, Wu, TC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3162874/ https://www.ncbi.nlm.nih.gov/pubmed/21798027 http://dx.doi.org/10.1186/2045-3701-1-26

Ejemplares similares

Efficient Delivery of DNA Vaccines using Human Papillomavirus Pseudovirions
por: Peng, Shiwen, et al.
Publicado: (2010)

Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells
por: Lamprecht, Renate L, et al.
Publicado: (2016)

Novel Production of Bovine Papillomavirus Pseudovirions in Tobacco Plants
por: Pietersen, Inge, et al.
Publicado: (2020)

Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions
por: Schäfer, Georgia, et al.
Publicado: (2017)

Papillomavirus pseudovirions packaged with the L2 gene induce cross-neutralizing antibodies
por: Combelas, Nicolas, et al.
Publicado: (2010)

Autophagy is induced in human keratinocytes during human papillomavirus 11 pseudovirion entry
por: Han, Rui, et al.
Publicado: (2020)

Measurement of Human Papillomavirus-Specific Antibodies Using a Pseudovirion-Based ELISA Method
por: Toh, Zheng Quan, et al.
Publicado: (2020)

Development of a Triple-Color Pseudovirion-Based Assay to Detect Neutralizing Antibodies against Human Papillomavirus
por: Nie, Jianhui, et al.
Publicado: (2016)

Ovarian Cancer Gene Therapy Using HPV-16 Pseudovirion Carrying the HSV-tk Gene
por: Hung, Chien-Fu, et al.
Publicado: (2012)

High-Throughput Pseudovirion-Based Neutralization Assay for Analysis of Natural and Vaccine-Induced Antibodies against Human Papillomaviruses
por: Sehr, Peter, et al.
Publicado: (2013)

Inhibition of Multidrug Resistance by SV40 Pseudovirion Delivery of an Antigene Peptide Nucleic Acid (PNA) in Cultured Cells
por: Macadangdang, Benjamin, et al.
Publicado: (2011)

Co-administration with DNA encoding papillomavirus capsid proteins enhances the antitumor effects generated by therapeutic HPV DNA vaccination
por: Yang, Benjamin, et al.
Publicado: (2015)

Local administration of granulocyte macrophage colony-stimulating factor induces local accumulation of dendritic cells and antigen-specific CD8+ T cells and enhances the efficacy of therapeutic vaccine in cervicovaginal tumor
por: Lee, Sung-Jong, et al.
Publicado: (2015)

Strategy for eliciting antigen-specific CD8+ T cell-mediated immune response against a cryptic CTL epitope of merkel cell polyomavirus large T antigen
por: Gomez, Bianca P, et al.
Publicado: (2012)

Thiol-reactive reagents inhibits intracellular trafficking of human papillomavirus type 16 pseudovirions by binding to cysteine residues of major capsid protein L1
por: Ishii, Yoshiyuki, et al.
Publicado: (2007)

Measurement of Neutralizing Serum Antibodies of Patients Vaccinated with Human Papillomavirus L1 or L2-Based Immunogens Using Furin-Cleaved HPV Pseudovirions
por: Wang, Joshua W., et al.
Publicado: (2014)

Enhancing antitumor immunogenicity of HPV16-E7 DNA vaccine by fusing DNA encoding E7-antigenic peptide to DNA encoding capsid protein L1 of Bovine papillomavirus
por: Yang, Andrew, et al.
Publicado: (2017)

Innovative DNA Vaccine for Human Papillomavirus (HPV)-Associated Head and Neck Cancer
por: Wu, Annie, et al.
Publicado: (2010)

Immunogenicity correlation in cynomolgus monkeys between Luminex‐based total IgG immunoassay and pseudovirion‐based neutralization assay for a 14‐valent recombinant human papillomavirus vaccine
por: Bei, Lei, et al.
Publicado: (2022)

Control of Tumors by Antigen-Specific CD8(+) T Cells through PDL1-Targeted Delivery of Antigenic Peptide
por: Feng, Po-Hao, et al.
Publicado: (2022)

Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry
por: Hindmarsh, Patrick L, et al.
Publicado: (2007)

Inhibitors of SARS-CoV entry – Identification using an internally-controlled dual envelope pseudovirion assay
por: Zhou, Yanchen, et al.
Publicado: (2011)

Optimization of SARS-CoV-2 Pseudovirion Production in Lentivirus Backbone With a Novel Liposomal System
por: Mahalingam, Gokulnath, et al.
Publicado: (2022)

Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control
por: Wu, Tc, et al.
Publicado: (2013)

Immunologic Control of Mus musculus Papillomavirus Type 1
por: Wang, Joshua W., et al.
Publicado: (2015)

In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination
por: Mao, Chih-Ping, et al.
Publicado: (2011)

Identification of human MHC-I HPV18 E6/E7-specific CD8 + T cell epitopes and generation of an HPV18 E6/E7-expressing adenosquamous carcinoma in HLA-A2 transgenic mice
por: Peng, Shiwen, et al.
Publicado: (2022)

Cryoablation therapy stimulates the antigen-specific T cell immune responses generated by therapeutic HPV DNA vaccine
por: Lee, Sung Yong, et al.
Publicado: (2015)

Development of a hybrid alphavirus-SARS-CoV-2 pseudovirion for rapid quantification of neutralization antibodies and antiviral drugs
por: Hetrick, Brian, et al.
Publicado: (2022)

Cytoplasmic Tail Truncation Stabilizes S1-S2 Association and Enhances S Protein Incorporation into SARS-CoV-2 Pseudovirions
por: Zhang, Lizhou, et al.
Publicado: (2023)

Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination
por: Tseng, Chih-Wen, et al.
Publicado: (2008)

Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines
por: Peng, Shiwen, et al.
Publicado: (2011)

Cognate Antigen Stimulation Generates Potent CD8(+) Inflammatory Effector T Cells
por: Sung, Hsueh-Cheng, et al.
Publicado: (2013)

Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a
por: Cheung, Ka Lun, et al.
Publicado: (2016)

Control of spontaneous ovarian tumors by CD8+ T cells through NKG2D-targeted delivery of antigenic peptide
por: Kang, Tae Heung, et al.
Publicado: (2013)

Costs of delivering human papillomavirus vaccination in Tanzania
por: Struckmann, V, et al.
Publicado: (2022)

Designing of CD8(+) and CD8(+)-overlapped CD4(+) epitope vaccine by targeting late and early proteins of human papillomavirus
por: Kaliamurthi, Satyavani, et al.
Publicado: (2018)

The timing of TGF-β inhibition affects the generation of antigen-specific CD8(+) T Cells
por: Quatromoni, Jon G, et al.
Publicado: (2013)

Generation of tumor antigen-specific CD4+ and CD8+ T cells by simultaneous MHC-I and -II epitope presentation in vitro and in vivo
por: Wehner, Carina, et al.
Publicado: (2014)

PSGL-1 Inhibits the Incorporation of SARS-CoV and SARS-CoV-2 Spike Glycoproteins into Pseudovirions and Impairs Pseudovirus Attachment and Infectivity
por: He, Sijia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hmd6e068mqqe962dk1ta4f3ts0